Abstract:The inadequate treatment efficacy, suboptimal cancer detection and disease monitoring in anticancer therapies have led to the quest for clinically relevant, innovative multifaceted solutions such as development of targeted and traceable approaches. Molecular imaging technologies with the versatility of liposomal nanoparticles platform offer tangible options to better guide treatment delivery and monitor outcome. In this study, we introduced noninvasive, quantitative and functional imaging techniques with reporter gene methods to probe breast cancer processes with liposomal nanoparticles by bioluminescence imaging (BLI). A breast cancer model was applied for therapy by injecting 5.0 x 10(5) 4T1 cells carrying a reporter system encoding a double fusion reporter gene consisting of firefly luciferase (Fluc) and green fluorescent protein (GFP) into BALB/c mice. Liposomal nanoparticles loaded with a triple fusion gene containing the herpes simplex virus truncated thymidine kinase (HSV-ttk) and renilla luciferase (Rluc) and red fluorescent protein (RFP) were applied by in situ injection for monitoring and evaluating gene therapy. The BALB/c mice were subsequently treated with ganciclovir (GCV) and the growth status of tumor was monitored by bioluminescence imaging of Fluc and the treatment delivery of liposomal nanoparticle was efficiently tracked by Rluc imaging. In fact, TF plasmids were shown to be useful for monitoring and evaluating targeting efficacy and gene therapy by non-invasive molecular imaging. In conclusion, the combination of noninvasive imaging techniques and liposomal nanoparticle can provide a practical and clinically useful way for gene delivery and monitoring the level of gene expression over time and treatment response in patients undergoing gene therapy.

Functional Nanoparticles for Molecular Imaging Guided Gene Delivery

Protein Nanoparticles Directed Cancer Imaging and Therapy

Functional Magnetic Nanoparticles for Non-Viral Gene Delivery and MR Imaging

Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor

Production and Clinical Development of Nanoparticles for Gene Delivery

Recent advances in nanomaterials with inherent optical and magnetic properties for bio-imaging and imaging-guided nucleic acid therapy.

Nanoparticles in Gene Therapy: Principles, Prospects, and Challenges

Nanomedicine For Drug Delivery And Imaging: A Promising Avenue For Cancer Therapy And Diagnosis Using Targeted Functional Nanoparticles

Progress on Magnetic Nanoparticles as Gene Delivery Carrier

Stimuli-Responsive Polymeric Nanocarriers for Efficient Gene Delivery

Nanoparticles for Gene Delivery: A Brief Patent Review

Gold-Nanorods-Based Gene Carriers with the Capability of Photoacoustic Imaging and Photothermal Therapy

Efficient Gene Delivery and Multimodal Imaging by Lanthanide-Based Upconversion Nanoparticles

Smart Polymeric Nanoparticles for Cancer Gene Delivery

Clinical Evaluations of Toxicity and Efficacy of Nanoparticle-Mediated Gene Therapy

Non-viral Gene Delivery Using Nanoparticles

[Nanobiotechnological Gene Transfer Vectors in Gene Therapy].

Assessment of therapeutic efficacy of liposomal nanoparticles mediated gene delivery by molecular imaging for cancer therapy.

Functional magnetic Prussian blue nanoparticles for enhanced gene transfection and photothermal ablation of tumor cells

Biomembrane-wrapped gene delivery nanoparticles for cancer therapy

Silica nanoparticles as promising drug/gene delivery carriers and fluorescent nano-probes: recent advances.